At the news
? BEARISHIMPACT 3/10 COURT-RULING filed Aug 30, 2026 at 20:00 ET
AstraZeneca's lawsuit challenging Colorado's 340B contract pharmacy protection law (S.B. 71) was dismissed with prejudice. The court rejected all constitutional claims (preemption, patent, Contracts Clause, Takings Clause), finding the law does not conflict with federal 340B requirements and that AstraZeneca's voluntary participation in 340B forecloses its takings argument. The ruling is consistent with a nationwide pattern of similar losses for drug manufacturers.
- AstraZeneca's constitutional challenge to Colorado's S.B. 71 (340B contract pharmacy protection) dismissed with prejudice on all claims
- Court found standing but rejected preemption, patent, Contracts Clause, and Takings Clause arguments
- AstraZeneca estimated $600,000/month loss from complying with S.B. 71's unlimited contract pharmacy requirement
- Ruling aligns with multiple other federal courts that have rejected similar manufacturer challenges to state 340B laws
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access